Melissa Lipari Pharm.D., BCACP

Melissa Lipari Pharm.D., BCACP

Title

Assistant Professor (Clinical)

Department

Pharmacy Practice

Office Location

Room 4137

Phone

313-993-7685

Email

mlipari@wayne.edu

Melissa Lipari Pharm.D., BCACP

Degrees and Certifications

Degrees
  • 2010 - Pharm.D., Wayne State University
  • 2006 - B.S. Pre-Pharmacy, Wayne State University
Certifications
  • 2017 - Diabetes Self-Management Facilitator Certificate, Lake Superior Quality Innovation Network
  • 2016 - Freedom from Smoking Facilitator Certificate, American Lung Association
  • 2013 - Care Management Certificate, MiPCT program
  • 2010 - Post-Graduate Teaching Certificate
  • 2008 - Pharmacy- Based Immunization Delivery Certificate

Positions and Employment

  • 2012-present - Assistant Professor (Clinical), Pharmacy Practice, Wayne State University

Awards and Honors

  • 2016 - Innovative Practice Award, Michigan Pharmacists Association
  • 2014 - ASHP Research Boot Camp Participant
  • 2013 - ASHP Best Practices in Health-system Pharmacy Award
  • 2012 - Resident of the Year, Southeastern Michigan Society of Health-System Pharmacists
  • 2012 - First Place Winner, Michigan Chapter ACC, Cardiovascular Summit
  • 2012 - Second Runner Up, ACCP Ambulatory Care/Endocrine Metabolism PRN Walk Rounds, American College of Clinical Pharmacy

Professional Memberships

  • 2009-present - American College of Clinical Pharmacy
  • 2009-present - American Society of Health-System Pharmacy
  • 2007-present - Michigan Pharmacists Association

Areas of Expertise

  • Chronic obstructive pulmonary disease (COPD)

Recent Publications

  • Wilhelm S, Lipari M. Nausea and vomiting. In: Chisholm-Burns MA, Schwinghammer TL, Wells BG, Malone PM, Kolesar JM, DiPiro JT, eds. Pharmacotherapy Principles & Practice. 5th ed. New York, NY: McGraw-Hill, 2019.
  • Wilhelm S, Lipari M. Nausea and vomiting. In: Chisholm-Burns MA, Schwinghammer TL, Wells BG, Malone PM, Kolesar JM, DiPiro JT, eds. Pharmacotherapy Principles & Practice. 4th ed. New York: McGraw-Hill, 2016.
  • Wilhelm S, Lipari M. Nausea and Vomiting. In: Crisholm-Burns MA, Schwinghammer TL, Wells BG, et al, eds. Pharmacotherapy Principles & Practice. 3rd ed. New York: McGraw-Hill, 2013.
  • Lipari M, Moser L, Saleh Y, Hang P. Understandability and Actionability of Diabetes Education Materials. Am J Health-Syst Pharm. 2019; 76(3): 182-186.
  • Sedlacek J, Giuliano CA, Baisden K, Lipari M. “Bite Sized” rivaroxaban patient education and its effect on knowledge. International Journal of Clinical Pharmacy. 2019, 41(1):6-8.
  • Lipari M, Smith AL, Kale-Pradhan PB, Wilhelm SM. Adherence to GOLD Guidelines in the Inpatient COPD Population. Journal of Pharmacy Practice. 2018, 31 (1): 29-33. DOI: 10.1177/0897190017696949
  • Flack JM, Moser LR, Lipari M, Petrovitch E, Farber M. In Response to “As-Needed Intravenous Antihypertensive Therapy and Blood Pressure Control.” J Hosp Med.2016; 11(7):526. DOI:10.002/jhm.2565.
  • Lipari M, Moser LR, Petrovitch EA, Farber M, Flack JM. As Needed IV Antihypertensive Therapy and Blood Pressure Control. J Hosp Med. 2016;11(3):193-8. DOI: 10.1002/jhm.2510. Published online first – Nov. 12, 2015.
  • Wilhelm SM, Lipari M, Kulik JK, Kale-Pradhan PB*. Teduglutide. Ann Pharmacother. 2014:48(9) 1209–13. DOI: 10.1177/1060028014537468
  • Lipari M, Benipal H, Kale-Pradhan P*. Roflumilast in the management of Chronic Obstructive Pulmonary Disease. Am J Health-Syst Pharm. 2013;70: 2087-95. DOI: 10.2146/ajhp130114
  • Lipari M, Kale-Pradhan PB*. Vulnerable COPD patients with comorbidities: the role of roflumilast. Ther Clin Risk Manag. 2014;10:969-976. DOI: 10.2147/TCRM.S55105
  • Lipari M, Garwood CL, Moser L. Identifying and Improving Medication Nonadherence: A Primer for Pharmacists. Michigan Pharmacist. 2015;53(1):41-44.
  • Lipari M, Wilhelm S, Kale-Pradhan P. Triple versus Monotherapy in COPD: A Meta-Analysis. Pharmacotherapy 2017, 37(12):236e
  • Lipari M, Wilhelm S, Kale-Pradhan P. Triple versus Dual Therapy in COPD: A Meta-Analysis. Pharmacotherapy 2017, 37(12):236e
  • Lipari M, Moser L, Saleh Y, Hang P. Understandability and Actionability of Diabetes Education Materials. American College of Clinical Pharmacy Virtual Poster Symposium. Pharmacotherapy. 2017;37(6): 39e-40e
  • Lipari M, Smith AL, Kale-Pradhan P, Wilhelm S. Adherence to GOLD Guidelines in the Inpatient Population. Pharmacotherapy 2016; 36(12): 272e.
  • Johnson J, Garwood C, Moser LR, Lipari M. Pharmacist Interventions and Healthcare Outcomes in a Novel Hearted Failure Clinic. Pharmacotherapy 2012; 32:183e.
  • Lipari M, Moser LR, Petrovitch, EA, Farber M, Flack J. As needed IV antihypertensive therapy and blood pressure control. Pharmacotherapy 2011; 31:314e.
  • Moser LR, Weber K, Lipari M, McGaffey K, Virant-Young D. Evaluation of a heparin dosing nomogram with emphasis on special patient populations. Pharmacotherapy 2009; 29:204e.